Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-071808
Filing Date
2025-07-29
Accepted
2025-07-29 17:23:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 17310
2 EXHIBIT 99.1 tm2521999d1_ex99-1.htm EX-99.1 9000
  Complete submission text file 0001104659-25-071808.txt   28064
Mailing Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121 858-369-7100
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-79594 | Film No.: 251163095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 830 BRICKELL PLAZA MIAMI FL 33131
Business Address 830 BRICKELL PLAZA MIAMI FL 33131 305-929-6851
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G